drug protocol number

ML22726

drug sponsor

Roche

drug study

Tocilizumab

drug trial site

King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah), Hira Hospital (Makkah)

drug status

Completed

drug phase